These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 2071894

  • 1. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis.
    Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M.
    J Immunol; 1991 Jul 15; 147(2):515-9. PubMed ID: 2071894
    [Abstract] [Full Text] [Related]

  • 2. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb 15; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 3. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
    Haas C, Ryffel B, Le Hir M.
    J Immunol; 1997 Jun 01; 158(11):5484-91. PubMed ID: 9164971
    [Abstract] [Full Text] [Related]

  • 4. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.
    Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH.
    J Immunol; 1987 Jun 01; 138(11):3785-92. PubMed ID: 3495570
    [Abstract] [Full Text] [Related]

  • 5. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.
    J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623
    [Abstract] [Full Text] [Related]

  • 6. Nephritogenic antibodies in MRL/lpr lupus mice: molecular characteristics in pathological and genetic aspects.
    Itoh J, Takahashi S, Ono M, Yamamoto T, Nose M, Kyogoku M.
    Tohoku J Exp Med; 1994 May 01; 173(1):65-74. PubMed ID: 7809912
    [Abstract] [Full Text] [Related]

  • 7. Studies on the mechanisms of the development of lupus nephritis in BXSB mice. II. Comparative studies between male BXSB and MRL/lpr mice at the onset period.
    Makino M, Fujiwara M, Watanabe H.
    J Clin Lab Immunol; 1988 Feb 01; 25(2):83-8. PubMed ID: 3259631
    [Abstract] [Full Text] [Related]

  • 8. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S, Nakamura Y, Sawasaki T, Endo Y, Nose M.
    Eur J Immunol; 2005 May 01; 35(5):1510-20. PubMed ID: 15832294
    [Abstract] [Full Text] [Related]

  • 9. [The pathogenesis of glomerulonephritis in MRL mice--murine lupus erythematosus].
    Hewicker M, Kromschröder E, Trautwein G.
    Verh Dtsch Ges Pathol; 1989 May 01; 73():129-32. PubMed ID: 2482597
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R, Shibata T, De Kossodo S, Izui S.
    Eur J Immunol; 1989 Nov 01; 19(11):2131-7. PubMed ID: 2599002
    [Abstract] [Full Text] [Related]

  • 11. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.
    J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922
    [Abstract] [Full Text] [Related]

  • 12. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 13. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM, Yui MA, Endres S, Burt DW, Kelley VE.
    J Immunol; 1988 Jul 01; 141(1):118-24. PubMed ID: 3259964
    [Abstract] [Full Text] [Related]

  • 14. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
    Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED.
    J Immunol; 1984 Jul 01; 133(1):227-33. PubMed ID: 6609979
    [Abstract] [Full Text] [Related]

  • 15. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 16. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
    Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW.
    J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582
    [Abstract] [Full Text] [Related]

  • 17. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R, Iwamoto M, Fossati L, Izui S.
    J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378
    [Abstract] [Full Text] [Related]

  • 18. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 01; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

  • 19. Arteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production.
    Nose M, Nishimura M, Ito MR, Toh J, Shibata T, Sugisaki T.
    Am J Pathol; 1996 Nov 01; 149(5):1763-9. PubMed ID: 8909264
    [Abstract] [Full Text] [Related]

  • 20. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
    Yoshida H, Yoshida M, Izui S, Lambert PH.
    J Clin Invest; 1985 Aug 01; 76(2):685-94. PubMed ID: 3875630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.